Description

Kabelline Fat Reduction Solution is an innovative approach to achieving the body contours you desire. Designed to improve the appearance and profile of moderate to severe fat on the body, Kabelline stands out as an effective solution.

The Science Behind Kabelline:
Our Kabelline products include the active ingredient, synthetic deoxycholic acid. This remarkable substance aids in the breakdown of fat and its absorption into the body. Notably, deoxycholic acid is a naturally occurring molecule in the human body.

Targeted Fat Reduction:

Fat tends to accumulate in troublesome areas such as the chin, face, and abdomen.
Kabelline, available as an injectable fat-reducing serum, excels at dissolving fat in these regions.
This fat dissolver works directly on fat cells, earning it recognition as one of South Korea’s best-selling solutions.
Key Benefits of Kabelline:

Offers a non-invasive alternative to surgery for destroying fat cells.
Features a double mechanism for inducing fat cell destruction.
Aids in achieving your fitness goals without leaving permanent marks.
FDA-approved for safety and effectiveness.
Quick results with a procedure that typically takes only 5 to 15 minutes.
Versatile application for face contouring and body slimming.
Scope of Kabelline:
Kabelline can effectively target local fat deposits and be injected into various body parts, excluding the cheeks. Common areas where Kabelline is used include:

Saggy/Double Chin
Fat pouches at the corner of the mouth
General V-line face
Abdominal region
Upper arms
Waist
Hips
Augmented fat depots located on buttocks
Inner and outer thighs
Effect Duration:
With proper diet and exercise, the effects of Kabelline can be permanent.

Product Composition:

Deoxycholic acid, 200 g
Kabelline Product Info:

Packaging: 5 vials x 8 ml per box
Injection Area: Middle of the fat pad and slightly more superficially in cases of cellulite, 1.5 cm apart
Storage: Room temperature (2~30℃), away from sunlight
Shelf Life: 24 months from the manufacturing date
Manufacturer: NeoGenesis Co., Ltd., South Korea